郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Benzimidazole-5-sulfonamides as novel nonpeptide luteinizing hormone releasing hormone (LHRH) antagonists: minimization of mechanism-based CYP3A4 inhibition.

期刊：Chemical & pharmaceutical bulletin发表年份：2005作者：Kentaro Hashimoto; Mikayo Kataoka; Miyuki Tatsuta; Kayo Yasoshima; Mako Yamamoto; Takeshi Yura; Noriyuki Yamamoto; Klaus Urbahns; Jang Bahadur Gupta; Yingfu Li
阅读更多 →

药效评价[Lysalbinic acid--a new absorption enhancer for the buccal delivery of peptide drugs].

期刊：Ukrains'kyi biokhimichnyi zhurnal (1999 )发表年份：2005作者：P L Starokadomskiĭ; I Ia Dubeĭ
阅读更多 →

药效评价High-resolution FISH analysis.

期刊：Current protocols in human genetics发表年份：2005作者：Henry H Q Heng; Bradford Windle; Lap-Chee Tsui
阅读更多 →

药效评价Discovery of a novel, potent and selective human beta3-adrenergic receptor agonist.

期刊：Bioorganic & medicinal chemistry letters发表年份：2005作者：Yutaka Nakajima; Hitoshi Hamashima; Ken-Ichi Washizuka; Yasuyo Tomishima; Hiroaki Ohtake; Emiko Imamura; Toshiko Miura; Hiroshi Kayakiri; Masayuki Kato
阅读更多 →